ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,564.41
1.08%
US Tech 100
19,280.40
-0.13%
Dow Jones
40,421.36
0.33%
Brent Oil
81.445
-0.09%
Bitcoin
66,901.94
-1.04%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Phaxiam Therapeutics (0QSS) Quote

Phaxiam Therapeutics

Phaxiam Therapeutics (0QSS)

LSE
71.025
0.00
( 0.00% )
Updated: 20:00:00
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
71.025
Bid
6.925
Ask
7.28
Volume
0.00
0.00 Day's Range 0.00
71.025 52 Week Range 71.025
Market Cap
4.315B
Previous Close
71.025
Open
-
Last Trade
(O)
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
30
Shares Outstanding
60,751,000
Dividend Yield
-
PE Ratio
-5.10
Earnings Per Share (EPS)
-0.39
Revenue
1.33M
Net Profit
-23.49M

About Phaxiam Therapeutics

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.phaxiam.com
Headquarters
Lyon, Rhone, Fra
Founded
1970
Phaxiam Therapeutics is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0QSS. The last closing price for Phaxiam Therapeutics was 71.03 €. Over the last year, Phaxiam Therapeutics shares have traded in a share price range of 71.025 € to 71.025 €.

Phaxiam Therapeutics currently has 60,751,000 shares outstanding. The market capitalization of Phaxiam Therapeutics is 4.31 € billion. Phaxiam Therapeutics has a price to earnings ratio (PE ratio) of -5.10.

0QSS Latest News

More News

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 1er juillet 2024

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 1er juillet 2024 Article 223-16 du Règlement Général de l’Autorité des Marchés...

July 03 2024
GlobeNewswire Inc.

Résultats de l'Assemblée Générale Mixte du 28 juin 2024

Résultats de l'Assemblée Générale Mixte du 28 juin 2024 Lyon (France) et Cambridge (MA, US), le 28 juin 2024 – 17h45 CEST – PHAXIAM Therapeutics (Euronext : PHXM ; FR0011471135) société...

June 28 2024
GlobeNewswire Inc.

PHAXIAM Therapeutics annonce le succès de son augmentation de capital avec maintien du droit préférentiel de souscription de 7,8 M€

PHAXIAM Therapeutics annonce le succès de son augmentation de capital avec maintien du droit préférentiel de souscription de 7,8 M€ Lyon (France), le 27 juin 2024 - 17h45 CEST - PHAXIAM...

June 27 2024
GlobeNewswire Inc.

Lancement d'une augmentation de capital avec maintien du DPS d’un montant d’environ 10 M€, susceptible d’être porté à environ 11,5 M€ en cas d’exercice intégral de la clause d'extension

Lancement d'une augmentation de capital avec maintien du DPS d’un montant d’environ 10 M€, susceptible d’être porté à environ 11,5 M€ en cas d’exercice intégral de la clause...

June 12 2024
GlobeNewswire Inc.

PHAXIAM annonce les modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 28 juin 2024

PHAXIAM annonce les modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 28 juin 2024 Lyon (France) et Cambridge (MA, US), le 7 juin 2024 – 17h45 CEST –...

June 07 2024
GlobeNewswire Inc.

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 mai 2024

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 mai 2024 Article 223-16 du Règlement Général de l’Autorité des Marchés...

June 05 2024
GlobeNewswire Inc.

PHAXIAM provides Business and Financial Update for the First Quarter of 2024

PHAXIAM provides Business and Financial Update for the First Quarter of 2024 PHAXIAM provides Business and Financial Update for the First Quarter of 2024 Webinar (in French) today, May 15...

May 15 2024
GlobeNewswire Inc.

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2024

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2024   Article 223-16 du Règlement Général de l’Autorité des Marchés...

May 03 2024
GlobeNewswire Inc.

PHAXIAM Announces 2023 Full-Year Results and Provides Business Update

PHAXIAM Announces 2023 Full-Year Results and Provides Business Update Conference call and webcast (English) on Thursday, March 21, 2024 at 9:30am ET / 2:30pm CET Ongoing clinical efforts boding...

March 20 2024
UK Regulatory

PHAXIAM Therapeutics publie ses résultats annuels 2023 et fait le point sur ses activités

PHAXIAM Therapeutics publie ses résultats annuels 2023 et fait le point sur ses activités Webinaire en français le jeudi 21 mars 2024 à 11h00 CET : inscrivez-vous ici Stratégie clinique en phase...

March 20 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40071.02571.02571.025271.025DE
120071.02571.02571.0253071.025DE
260071.02571.02571.0252271.025DE
520071.02571.02571.025270071.025DE
1560071.02571.02571.025703071.025DE
2600071.02571.02571.025488571.025DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NMHINatures Miracle Holding Inc
$ 0.8398
(139.94%)
7.95M
WRNTWarrantee Inc
$ 0.5991
(105.88%)
8.06M
FEIMFrequency Electronics Inc
$ 13.75
(36.14%)
115.83k
TUSKMammoth Energy Services Inc
$ 4.50
(28.57%)
65.83k
LGHLWLion Group Holding Ltd
$ 0.0091
(28.17%)
4.5k
RNAZTransCode Therapeutics Inc
$ 0.3274
(-58.69%)
418.09k
MIRAMIRA Pharmaceuticals Inc
$ 3.49
(-30.34%)
943.44k
CMAXCareMax Inc
$ 3.82
(-26.40%)
323.75k
BREABrera Holdings PLC
$ 0.5754
(-21.94%)
1.74M
NUKKNukkleus Inc
$ 0.3998
(-19.72%)
147.77k
WRNTWarrantee Inc
$ 0.5851
(101.07%)
8.07M
NMHINatures Miracle Holding Inc
$ 0.8452
(141.49%)
7.97M
LIFWMSP Recovery Inc
$ 0.5675
(12.00%)
4.38M
BREABrera Holdings PLC
$ 0.577
(-21.72%)
1.74M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 14.50
(1.47%)
1.49M

Discussion

View Full Feed
TRUSTUNITS1000000 TRUSTUNITS1000000 3 minutes ago
Wonder how it tasted
VGID
TRUSTUNITS1000000 TRUSTUNITS1000000 3 minutes ago
Neat drink design
VGID
TRUSTUNITS1000000 TRUSTUNITS1000000 4 minutes ago
No volume
FMNJ
TRUSTUNITS1000000 TRUSTUNITS1000000 5 minutes ago
Can buy u,s.
DCMDF
TRUSTUNITS1000000 TRUSTUNITS1000000 5 minutes ago
Interesting what they do
DCMDF
StockWorkOrange StockWorkOrange 6 minutes ago
Imagine that, Benny pops up and so does Alidare. This guy is as slimy as they come. Blocks and runs on ST and X when you expose him.....
AABB
TRUSTUNITS1000000 TRUSTUNITS1000000 7 minutes ago
Interesting 🤔 comment
AABB
Mark Mark 7 minutes ago
$WRNT & $NMHI top two gainers so far, one over 200%, one over 100%
NMHI WRNT
VDB1 VDB1 8 minutes ago
Lightwave Logic's choice to bring Le Maitre on board underscores the company's commitment to leadership with deep industry knowledge.

In other recent news, Lightwave Logic has made significant strides in its commercial strategy and technological advancements. The company has emphas
LWLG
Nerd Beautiful Nerd Beautiful 8 minutes ago
Two happy things I just remembered. Tony said there were good things in the works earlier this year. I just rediscovered the ignore this member button
LQMT
goldslacker2023 goldslacker2023 9 minutes ago
Words of wisdom; Be careful to not lock the knees. Better balance in the event there's ever a pendulum swing in life. Is it just me or have you noticed any volume lately in the OTC? Tread heavy. New tires but it cost me. You play you pay. Tallyho!
GNCP
TRUSTUNITS1000000 TRUSTUNITS1000000 9 minutes ago
TGGI huge company in the making, maybe
TGGI
WooptdooU WooptdooU 9 minutes ago
Maybe this guy will help get the ceo and cob into separate bodies. Right now you have a KNOWN MISGUIDER acting as both! This , ahem, "expert witness" corporate welfarist has groomed his family long enough off the back of capitalism...
LWLG
Awl416 Awl416 9 minutes ago
New lows
DRMA
Awl416 Awl416 10 minutes ago
Ready?
ZEO
TRUSTUNITS1000000 TRUSTUNITS1000000 10 minutes ago
EEENF can’t go wrong at these prices
EEENF
abrooklyn abrooklyn 11 minutes ago
https://pr.tsmc.com/system/files/newspdf/attachment/09349f4b044016a40b284519b3c86005b578749f/2Q24%20%28E%29_with%20guidance_final_wmn.pdf

TSMC Reports Second Quarter EPS of NT$9.56
HSINCHU, Taiwan, R.O.C., Jul. 18, 2024 -- TSMC (TWSE: 2330, NYSE: TSM) today
announced con
TSM
Pennies_Envy Pennies_Envy 11 minutes ago
Nothing really new in the q&a but glad they are posting
HIRU
TRUSTUNITS1000000 TRUSTUNITS1000000 11 minutes ago
Don’t let the shares outstanding scare you, this can run quickly
EEENF
primecomm primecomm 12 minutes ago
Good Morning $RNVA
RNVA
TRUSTUNITS1000000 TRUSTUNITS1000000 12 minutes ago
Management is going to make us happy $$$$$$$
EEENF
LVerstee LVerstee 12 minutes ago
Thanks for the explanation. What you’re describing sounds like a potential pump-and-dump scheme. Doubling profits every 15 days and constantly increasing yields seems pretty unrealistic. What study or source is this based on? Claims that the token is "too cheap" and predictions of it reaching $100 s
ITUP
HD2001 HD2001 13 minutes ago
Lies audits, QB listening ,funding , many acquisitions, filing dates, Reg-A ,revenue, profits, there's zero chance of xalles being truthful.
XALL
MightyX MightyX 13 minutes ago
Retail-trader-group-fraud offset nearly 50% by restricted-OS overnight
TPTW
mfaphoto mfaphoto 13 minutes ago
But the fee to buy them is $6.95, so they will cost you about 4 cents each.
NSAV

Your Recent History

LSE
0QSS
Phaxiam Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved